6-carboxyfluorescein has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foley, JD; Heath, TD; McAnulty, JF; Murphy, CJ; Reid, TW; Waller, KR | 1 |
| Cormack, R; Gultepe, E; Jost, E; Levy, CO; Makrigiorgos, GM; Nagesha, D; Singh, S; Sridhar, S; Tada, DB | 1 |
2 other study(ies) available for 6-carboxyfluorescein and paclitaxel
| Article | Year |
|---|---|
Suppression of cold ischemic injury in stored kidneys by the antimicrobial peptide bactenecin.
Topics: Actins; Adenosine; Allopurinol; Animals; Antimicrobial Cationic Peptides; Cell Line; Cold Temperature; Cryopreservation; Culture Media, Serum-Free; Cytoskeleton; Dogs; Dose-Response Relationship, Drug; Female; Fluoresceins; Glutathione; Insulin; Ischemia; Kidney; Kidney Tubules; Liposomes; Membranes; Microtubules; Mitogens; Organ Preservation; Organ Preservation Solutions; Paclitaxel; Peptides, Cyclic; Permeability; Protein Binding; Raffinose; Reperfusion Injury; Stereoisomerism; Temperature; Time Factors | 2004 |
Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Drug Stability; Fluoresceins; Gold; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2010 |